vs
PTC THERAPEUTICS, INC.(PTCT)与Ribbon Communications Inc.(RBBN)财务数据对比。点击上方公司名可切换其他公司
PTC THERAPEUTICS, INC.的季度营收约是Ribbon Communications Inc.的1.0倍($164.7M vs $162.6M),Ribbon Communications Inc.净利率更高(54.8% vs -82.0%,领先136.7%),Ribbon Communications Inc.同比增速更快(-10.3% vs -22.7%),过去两年Ribbon Communications Inc.的营收复合增速更高(-8.1% vs -11.5%)
PTC Therapeutics是一家总部位于美国的制药企业,专注于开发口服小分子药物及基因疗法,通过靶向转录后调控机制调节基因表达,相关产品管线主要面向罕见病治疗领域,致力于满足相关疾病未被覆盖的临床治疗需求。
睿宾通信公司(Ribbon Communications Inc.)主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立,总部位于美国得克萨斯州普莱诺,是一家上市科技企业。
PTCT vs RBBN — 直观对比
营收规模更大
PTCT
是对方的1.0倍
$162.6M
营收增速更快
RBBN
高出12.4%
-22.7%
净利率更高
RBBN
高出136.7%
-82.0%
两年增速更快
RBBN
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $164.7M | $162.6M |
| 净利润 | $-135.0M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | -43.3% | 37.6% |
| 净利率 | -82.0% | 54.8% |
| 营收同比 | -22.7% | -10.3% |
| 净利润同比 | -104.8% | — |
| 每股收益(稀释后) | $-1.63 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PTCT
RBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $164.7M | $227.3M | ||
| Q3 25 | $211.0M | $215.4M | ||
| Q2 25 | $178.9M | $220.6M | ||
| Q1 25 | $1.2B | $181.3M | ||
| Q4 24 | $213.2M | $251.4M | ||
| Q3 24 | $196.8M | $210.2M | ||
| Q2 24 | $186.7M | $192.6M |
净利润
PTCT
RBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $-135.0M | — | ||
| Q3 25 | $15.9M | $-12.1M | ||
| Q2 25 | $-64.8M | $-11.1M | ||
| Q1 25 | $866.6M | $-26.2M | ||
| Q4 24 | $-65.9M | — | ||
| Q3 24 | $-106.7M | $-13.4M | ||
| Q2 24 | $-99.2M | $-16.8M |
毛利率
PTCT
RBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率
PTCT
RBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | -43.3% | 4.1% | ||
| Q3 25 | 1.4% | 1.3% | ||
| Q2 25 | -19.5% | 1.9% | ||
| Q1 25 | 82.5% | -10.8% | ||
| Q4 24 | -76.2% | 13.2% | ||
| Q3 24 | -27.7% | -0.4% | ||
| Q2 24 | -21.5% | -1.0% |
净利率
PTCT
RBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | -82.0% | — | ||
| Q3 25 | 7.5% | -5.6% | ||
| Q2 25 | -36.3% | -5.0% | ||
| Q1 25 | 73.7% | -14.5% | ||
| Q4 24 | -30.9% | — | ||
| Q3 24 | -54.2% | -6.4% | ||
| Q2 24 | -53.1% | -8.7% |
每股收益(稀释后)
PTCT
RBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-1.63 | $0.50 | ||
| Q3 25 | $0.20 | $-0.07 | ||
| Q2 25 | $-0.83 | $-0.06 | ||
| Q1 25 | $10.04 | $-0.15 | ||
| Q4 24 | $-0.85 | $0.05 | ||
| Q3 24 | $-1.39 | $-0.08 | ||
| Q2 24 | $-1.29 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-205.3M | $419.1M |
| 总资产 | $2.9B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PTCT
RBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $1.9B | $96.4M | ||
| Q3 25 | $1.7B | $74.8M | ||
| Q2 25 | $2.0B | $60.5M | ||
| Q1 25 | $2.0B | $71.2M | ||
| Q4 24 | $1.1B | $87.8M | ||
| Q3 24 | $1.0B | $37.2M | ||
| Q2 24 | $1.1B | $64.6M |
总债务
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益
PTCT
RBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $-205.3M | $449.0M | ||
| Q3 25 | $-155.8M | $360.1M | ||
| Q2 25 | $-206.5M | $370.4M | ||
| Q1 25 | $-185.8M | $381.8M | ||
| Q4 24 | $-1.1B | $404.6M | ||
| Q3 24 | $-1.1B | $395.5M | ||
| Q2 24 | $-980.2M | $405.0M |
总资产
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | $2.6B | $1.1B | ||
| Q2 25 | $2.6B | $1.1B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $1.9B | $1.1B |
负债/权益比
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-34.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | — |
| 自由现金流率自由现金流/营收 | -22.3% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $702.3M | — |
8季度趋势,按日历期对齐
经营现金流
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $-34.3M | $29.2M | ||
| Q3 25 | $-66.3M | $26.5M | ||
| Q2 25 | $-58.3M | $-795.0K | ||
| Q1 25 | $870.1M | $-3.5M | ||
| Q4 24 | $-30.0M | $61.8M | ||
| Q3 24 | $-77.0M | $-14.8M | ||
| Q2 24 | $-71.5M | $-9.8M |
自由现金流
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | $-36.6M | $27.3M | ||
| Q3 25 | $-69.7M | $21.0M | ||
| Q2 25 | $-59.6M | $-6.5M | ||
| Q1 25 | $868.4M | $-15.7M | ||
| Q4 24 | $-33.8M | $53.8M | ||
| Q3 24 | $-77.5M | $-23.7M | ||
| Q2 24 | $-78.8M | $-12.9M |
自由现金流率
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | -22.3% | 12.0% | ||
| Q3 25 | -33.1% | 9.7% | ||
| Q2 25 | -33.3% | -2.9% | ||
| Q1 25 | 73.8% | -8.7% | ||
| Q4 24 | -15.8% | 21.4% | ||
| Q3 24 | -39.4% | -11.3% | ||
| Q2 24 | -42.2% | -6.7% |
资本支出强度
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 0.9% | ||
| Q3 25 | 1.6% | 2.6% | ||
| Q2 25 | 0.7% | 2.6% | ||
| Q1 25 | 0.1% | 6.7% | ||
| Q4 24 | 1.8% | 3.2% | ||
| Q3 24 | 0.3% | 4.2% | ||
| Q2 24 | 4.0% | 1.6% |
现金转化率
PTCT
RBBN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTCT
暂无分部数据
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |